ORGANON & CO (OGN) Stock News

USA - NYSE:OGN - US68622V1061 - Common Stock

10.45 USD

-0.4 (-3.69%)

Last: 9/19/2025, 8:04:01 PM

10.45 USD

0 (0%)

After Hours: 9/19/2025, 8:04:01 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

OGN Latest News, Press Relases and Analysis

All

Press Releases

10 days ago - By: Zacks Investment Research

Organon (OGN) Stock Declines While Market Improves: Some Information for Investors

11 days ago - By: Kuehn Law, PLLC

Kuehn Law Encourages Investors of Organon & Co. to Contact Law Firm

19 days ago - By: Organon & Co.

US Food and Drug Administration (FDA) Approves Henlius and Organon’s BILDYOS® (denosumab-nxxp) and BILPREVDA® (denosumab-nxxp), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively

a month ago - By: Zacks Investment Research - Mentions: HQY

OGN vs. HQY: Which Stock Is the Better Value Option?

23 days ago - By: Yahoo Finance

Organon & Co. (OGN) Advances VTAMA Cream, Strengthens Women’s Health Portfolio

2 months ago - By: The Motley Fool

Organon (OGN) Fiscal Q2 Revenue Beats 1%

a month ago - By: Shareholders Foundation, Inc.

NYSE: OGN Lawsuit Alert: Investors who lost money with Organon & Co. (NYSE: OGN) shares should contact the Shareholders Foundation

a month ago - By: Zacks Investment Research

Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know

a month ago - By: Yahoo Finance

Organon & Co. (OGN) Reports Q2 2025 Results

2 months ago - By: Benzinga - Mentions: AFG CXDO YUM PACK ...

Earnings Scheduled For August 5, 2025

2 months ago - By: Benzinga

A Look Ahead: Organon's Earnings Forecast

2 months ago - By: Yahoo Finance

Organon & Co. (OGN) Slashes 13.13% on Disappointing Earnings

2 months ago - By: Zacks Investment Research

Organon (OGN) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

2 months ago - By: Zacks Investment Research - Mentions: CRL

Organon (OGN) Beats Q2 Earnings and Revenue Estimates

2 months ago - By: Organon & Co.

Organon Reports Results for the Second Quarter Ended June 30, 2025

2 months ago - By: Zacks Investment Research

Insights Into Organon (OGN) Q2: Wall Street Projections for Key Metrics

2 months ago - By: Zacks Investment Research

Organon (OGN) Sees a More Significant Dip Than Broader Market: Some Facts to Know

2 months ago - By: Zacks Investment Research - Mentions: BTSG

Organon (OGN) Expected to Beat Earnings Estimates: Should You Buy?

2 months ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Organon & Co. of Class Action Lawsuit and Upcoming Deadlines - OGN

2 months ago - By: Faruqi & Faruqi, LLP

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Organon

2 months ago - By: Levi & Korsinsky, LLP

Organon & Co. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before July 22, 2025 to Discuss Your Rights - OGN

2 months ago - By: Bragar Eagel & Squire

ORGANON FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Organon & Co. (OGN) Investors of the July 22nd Deadline and Urges Them to Inquire About Their Rights in Class Action Lawsuit

2 months ago - By: Organon & Co.

Organon To Report Second Quarter 2025 Results and Host Conference Call on August 5, 2025

2 months ago - By: The Law Offices of Frank R. Cruz

Deadline Soon: Organon & Co. (OGN) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

2 months ago - By: Berger Montague

DEADLINE TOMORROW: Berger Montague Advises Organon & Co. (NYSE: OGN) Investors to Inquire About a Securities Fraud Class Action by July 22, 2025

2 months ago - By: DJS Law Group LLP

News Image

OGN Shareholders Have the Right to Lead the Organon & Co. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - OGN